Did CEO Jeff Kindler get pushed out because he was shaking up the dysfunctional pharmaceutical giant -- or because he's an ineffective leader?
China will spend billions on biotech, even as the industry struggles in the U.S. to turn research into gold. Will U.S. biotech become the next Detroit?
A huge part of Allergan's patent-cliff immunity against other big pharmaceuticals is its blockbuster Botox, which has helped the company evade the patent problems facing others in the industry.
India's Ranbaxy won the right to make a generic version of the $11 billion drug -- only to be accused of seri ous fraud and shoddy practices in another case. Now a fight is erupting over the mega-popular cholesterol medication.
There's one cardinal rule for holiday parties: celebrate in moderation. But why leave it at that? Here's the sage advice we have received so far.
Usually thought of as a budget brand, Kia has delivered a comfortable and engaging large near luxury sedan.
Thick smog in Shanghai has forced flight cancellations and school closures.
Small business owners are able to bring new, innovative products to market faster and cheaper thanks to 3-D printers.
A name change can sometimes cause a company more trouble than it's worth.
A spy virus stole millions of passwords. Here's how to keep your password secure.
A time-tested group of elite fund managers offer their best stock ideas for 2014.
For an exclusive CNNMoney list, research firm Universum surveyed engineering and IT students in Europe to see where they most want to work.
The 2015 Ford Mustang will offer a few things you might not expect but engineers promise it will be the best ever.
|Homeless college students seek shelter during breaks|
|GM names Mary Barra as new CEO|
|Budget deal hits federal workers|
|Five things you didn't know about Bernie Madoff's epic scam|
|Snowden docs had NYTimes exec fearing for his life|